Cargando…
Prognostic value of complement serum C3 level and glomerular C3 deposits in anti-glomerular basement membrane disease
BACKGROUND AND OBJECTIVES: Activation of the complement system is involved in the pathogenesis of anti-glomerular basement membrane (anti-GBM) disease. Glomerular deposits of complement 3 (C3) are often detected on kidney biopsies. The primary objective of this study was to analyze the prognostic va...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10354545/ https://www.ncbi.nlm.nih.gov/pubmed/37475859 http://dx.doi.org/10.3389/fimmu.2023.1190394 |
_version_ | 1785074951442661376 |
---|---|
author | Caillard, Pauline Vigneau, Cécile Halimi, Jean-Michel Hazzan, Marc Thervet, Eric Heitz, Morgane Juillard, Laurent Audard, Vincent Rabant, Marion Hertig, Alexandre Subra, Jean-François Vuiblet, Vincent Guerrot, Dominique Tamain, Mathilde Essig, Marie Lobbedez, Thierry Quemeneur, Thomas Legendre, Mathieu Ganea, Alexandre Peraldi, Marie-Noëlle Vrtovsnik, François Daroux, Maïté Makdassi, Raïfah Choukroun, Gabriel Titeca-Beauport, Dimitri |
author_facet | Caillard, Pauline Vigneau, Cécile Halimi, Jean-Michel Hazzan, Marc Thervet, Eric Heitz, Morgane Juillard, Laurent Audard, Vincent Rabant, Marion Hertig, Alexandre Subra, Jean-François Vuiblet, Vincent Guerrot, Dominique Tamain, Mathilde Essig, Marie Lobbedez, Thierry Quemeneur, Thomas Legendre, Mathieu Ganea, Alexandre Peraldi, Marie-Noëlle Vrtovsnik, François Daroux, Maïté Makdassi, Raïfah Choukroun, Gabriel Titeca-Beauport, Dimitri |
author_sort | Caillard, Pauline |
collection | PubMed |
description | BACKGROUND AND OBJECTIVES: Activation of the complement system is involved in the pathogenesis of anti-glomerular basement membrane (anti-GBM) disease. Glomerular deposits of complement 3 (C3) are often detected on kidney biopsies. The primary objective of this study was to analyze the prognostic value of the serum C3 level and the presence of C3 glomerular deposits in patients with anti-GBM disease. METHODS: We conducted a retrospective cohort study of 150 single-positive patients with anti-GBM disease diagnosed between 1997 and 2017. Patients were categorized according to the serum C3 level (forming a low C3 (C3<1.23 g/L) and a high C3 (C3≥1.23 g/L) groups) and positivity for C3 glomerular staining (forming the C3+ and C3- groups). The main outcomes were kidney survival and patient survival. RESULTS: Of the 150 patients included, 89 (65%) were men. The median [interquartile range (IQR)] age was 45 [26–64]. At diagnosis, kidney involvement was characterized by a median [IQR] peak serum creatinine (SCr) level of 578 [298–977] µmol/L, and 106 (71%) patients required dialysis. Patients in the low C3 group (72 patients) had more severe kidney disease at presentation, as characterized by higher prevalences of oligoanuria, peak SCr ≥500 µmol/L (69%, vs. 53% in the high C3 group; p=0.03), nephrotic syndrome (42%, vs. 24%, respectively; p=0.02) and fibrous forms on the kidney biopsy (21%, vs. 8%, respectively; p=0.04). Similarly, we observed a negative association between the presence of C3 glomerular deposits (in 52 (41%) patients) and the prevalence of cellular forms (83%, vs. 58% in the C3- group; p=0.003) and acute tubulo-interstitial lesions (60%, vs. 36% in the C3- group; p=0.007). When considering patients not on dialysis at diagnosis, the kidney survival rate at 12 months was poorer in the C3+ group (50% [25-76], vs. 91% [78-100] in the C3- group; p=0.01), with a hazard ratio [95% confidence interval] of 5.71 [1.13-28.85] (p=0.04, after adjusting for SCr). CONCLUSION: In patients with anti-GBM disease, a low serum C3 level and the presence of C3 glomerular deposits were associated with more severe disease and histological kidney involvement at diagnosis. In patients not on dialysis at diagnosis, the presence of C3 deposits was associated with worse kidney survival. |
format | Online Article Text |
id | pubmed-10354545 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-103545452023-07-20 Prognostic value of complement serum C3 level and glomerular C3 deposits in anti-glomerular basement membrane disease Caillard, Pauline Vigneau, Cécile Halimi, Jean-Michel Hazzan, Marc Thervet, Eric Heitz, Morgane Juillard, Laurent Audard, Vincent Rabant, Marion Hertig, Alexandre Subra, Jean-François Vuiblet, Vincent Guerrot, Dominique Tamain, Mathilde Essig, Marie Lobbedez, Thierry Quemeneur, Thomas Legendre, Mathieu Ganea, Alexandre Peraldi, Marie-Noëlle Vrtovsnik, François Daroux, Maïté Makdassi, Raïfah Choukroun, Gabriel Titeca-Beauport, Dimitri Front Immunol Immunology BACKGROUND AND OBJECTIVES: Activation of the complement system is involved in the pathogenesis of anti-glomerular basement membrane (anti-GBM) disease. Glomerular deposits of complement 3 (C3) are often detected on kidney biopsies. The primary objective of this study was to analyze the prognostic value of the serum C3 level and the presence of C3 glomerular deposits in patients with anti-GBM disease. METHODS: We conducted a retrospective cohort study of 150 single-positive patients with anti-GBM disease diagnosed between 1997 and 2017. Patients were categorized according to the serum C3 level (forming a low C3 (C3<1.23 g/L) and a high C3 (C3≥1.23 g/L) groups) and positivity for C3 glomerular staining (forming the C3+ and C3- groups). The main outcomes were kidney survival and patient survival. RESULTS: Of the 150 patients included, 89 (65%) were men. The median [interquartile range (IQR)] age was 45 [26–64]. At diagnosis, kidney involvement was characterized by a median [IQR] peak serum creatinine (SCr) level of 578 [298–977] µmol/L, and 106 (71%) patients required dialysis. Patients in the low C3 group (72 patients) had more severe kidney disease at presentation, as characterized by higher prevalences of oligoanuria, peak SCr ≥500 µmol/L (69%, vs. 53% in the high C3 group; p=0.03), nephrotic syndrome (42%, vs. 24%, respectively; p=0.02) and fibrous forms on the kidney biopsy (21%, vs. 8%, respectively; p=0.04). Similarly, we observed a negative association between the presence of C3 glomerular deposits (in 52 (41%) patients) and the prevalence of cellular forms (83%, vs. 58% in the C3- group; p=0.003) and acute tubulo-interstitial lesions (60%, vs. 36% in the C3- group; p=0.007). When considering patients not on dialysis at diagnosis, the kidney survival rate at 12 months was poorer in the C3+ group (50% [25-76], vs. 91% [78-100] in the C3- group; p=0.01), with a hazard ratio [95% confidence interval] of 5.71 [1.13-28.85] (p=0.04, after adjusting for SCr). CONCLUSION: In patients with anti-GBM disease, a low serum C3 level and the presence of C3 glomerular deposits were associated with more severe disease and histological kidney involvement at diagnosis. In patients not on dialysis at diagnosis, the presence of C3 deposits was associated with worse kidney survival. Frontiers Media S.A. 2023-07-05 /pmc/articles/PMC10354545/ /pubmed/37475859 http://dx.doi.org/10.3389/fimmu.2023.1190394 Text en Copyright © 2023 Caillard, Vigneau, Halimi, Hazzan, Thervet, Heitz, Juillard, Audard, Rabant, Hertig, Subra, Vuiblet, Guerrot, Tamain, Essig, Lobbedez, Quemeneur, Legendre, Ganea, Peraldi, Vrtovsnik, Daroux, Makdassi, Choukroun and Titeca-Beauport https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Immunology Caillard, Pauline Vigneau, Cécile Halimi, Jean-Michel Hazzan, Marc Thervet, Eric Heitz, Morgane Juillard, Laurent Audard, Vincent Rabant, Marion Hertig, Alexandre Subra, Jean-François Vuiblet, Vincent Guerrot, Dominique Tamain, Mathilde Essig, Marie Lobbedez, Thierry Quemeneur, Thomas Legendre, Mathieu Ganea, Alexandre Peraldi, Marie-Noëlle Vrtovsnik, François Daroux, Maïté Makdassi, Raïfah Choukroun, Gabriel Titeca-Beauport, Dimitri Prognostic value of complement serum C3 level and glomerular C3 deposits in anti-glomerular basement membrane disease |
title | Prognostic value of complement serum C3 level and glomerular C3 deposits in anti-glomerular basement membrane disease |
title_full | Prognostic value of complement serum C3 level and glomerular C3 deposits in anti-glomerular basement membrane disease |
title_fullStr | Prognostic value of complement serum C3 level and glomerular C3 deposits in anti-glomerular basement membrane disease |
title_full_unstemmed | Prognostic value of complement serum C3 level and glomerular C3 deposits in anti-glomerular basement membrane disease |
title_short | Prognostic value of complement serum C3 level and glomerular C3 deposits in anti-glomerular basement membrane disease |
title_sort | prognostic value of complement serum c3 level and glomerular c3 deposits in anti-glomerular basement membrane disease |
topic | Immunology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10354545/ https://www.ncbi.nlm.nih.gov/pubmed/37475859 http://dx.doi.org/10.3389/fimmu.2023.1190394 |
work_keys_str_mv | AT caillardpauline prognosticvalueofcomplementserumc3levelandglomerularc3depositsinantiglomerularbasementmembranedisease AT vigneaucecile prognosticvalueofcomplementserumc3levelandglomerularc3depositsinantiglomerularbasementmembranedisease AT halimijeanmichel prognosticvalueofcomplementserumc3levelandglomerularc3depositsinantiglomerularbasementmembranedisease AT hazzanmarc prognosticvalueofcomplementserumc3levelandglomerularc3depositsinantiglomerularbasementmembranedisease AT therveteric prognosticvalueofcomplementserumc3levelandglomerularc3depositsinantiglomerularbasementmembranedisease AT heitzmorgane prognosticvalueofcomplementserumc3levelandglomerularc3depositsinantiglomerularbasementmembranedisease AT juillardlaurent prognosticvalueofcomplementserumc3levelandglomerularc3depositsinantiglomerularbasementmembranedisease AT audardvincent prognosticvalueofcomplementserumc3levelandglomerularc3depositsinantiglomerularbasementmembranedisease AT rabantmarion prognosticvalueofcomplementserumc3levelandglomerularc3depositsinantiglomerularbasementmembranedisease AT hertigalexandre prognosticvalueofcomplementserumc3levelandglomerularc3depositsinantiglomerularbasementmembranedisease AT subrajeanfrancois prognosticvalueofcomplementserumc3levelandglomerularc3depositsinantiglomerularbasementmembranedisease AT vuibletvincent prognosticvalueofcomplementserumc3levelandglomerularc3depositsinantiglomerularbasementmembranedisease AT guerrotdominique prognosticvalueofcomplementserumc3levelandglomerularc3depositsinantiglomerularbasementmembranedisease AT tamainmathilde prognosticvalueofcomplementserumc3levelandglomerularc3depositsinantiglomerularbasementmembranedisease AT essigmarie prognosticvalueofcomplementserumc3levelandglomerularc3depositsinantiglomerularbasementmembranedisease AT lobbedezthierry prognosticvalueofcomplementserumc3levelandglomerularc3depositsinantiglomerularbasementmembranedisease AT quemeneurthomas prognosticvalueofcomplementserumc3levelandglomerularc3depositsinantiglomerularbasementmembranedisease AT legendremathieu prognosticvalueofcomplementserumc3levelandglomerularc3depositsinantiglomerularbasementmembranedisease AT ganeaalexandre prognosticvalueofcomplementserumc3levelandglomerularc3depositsinantiglomerularbasementmembranedisease AT peraldimarienoelle prognosticvalueofcomplementserumc3levelandglomerularc3depositsinantiglomerularbasementmembranedisease AT vrtovsnikfrancois prognosticvalueofcomplementserumc3levelandglomerularc3depositsinantiglomerularbasementmembranedisease AT darouxmaite prognosticvalueofcomplementserumc3levelandglomerularc3depositsinantiglomerularbasementmembranedisease AT makdassiraifah prognosticvalueofcomplementserumc3levelandglomerularc3depositsinantiglomerularbasementmembranedisease AT choukroungabriel prognosticvalueofcomplementserumc3levelandglomerularc3depositsinantiglomerularbasementmembranedisease AT titecabeauportdimitri prognosticvalueofcomplementserumc3levelandglomerularc3depositsinantiglomerularbasementmembranedisease |